Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha

Lymphokine Cytokine Res. 1991 Aug;10(4):307-15.

Abstract

Lymphocytes infiltrating ovarian malignant ascites (TALs) were propagated in vitro in the presence of low (20-50 U/ml) concentrations of recombinant interleukin-2 (rIL-2) and moderate concentrations of interleukin-4 (IL-4) and tumor necrosis factor type alpha (TNF-alpha). Neither IL-4 nor TNF-alpha alone induced proliferation of ovarian TALs, but IL-4 and TNF-alpha synergized with IL-2 in enhancing the proliferation of T cells from cultures and inducing a more specific pattern of cytotoxic responses of ovarian TAL. IL-4 enhanced the proliferation of TAL cultures in the induction phase, but did not synergize with IL-2 in enhancing the proliferation and cytotoxicity of an established autologous tumor-specific CD8+/CD4- cytotoxic T lymphocyte (CTL) line. In contrast, TNF-alpha-induced preferential expansion of CD8+ CTL in TAL cultures where CD3+/CD4+ cells were initially in excess and of an established autologous tumor-specific CD8+ CTL line. This expansion resulted in increased levels of cytoxicity against autologous tumor cells. Amplification of IL-2 growth-promoting effects and selective enrichment in T cell subsets by IL-4 and TNF-alpha may therefore be useful in cellular adoptive immunotherapy using tumor-specific T cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / immunology*
  • Ascites / immunology
  • CD8 Antigens / analysis
  • Cytotoxicity, Immunologic / drug effects
  • Female
  • Humans
  • Interleukin-2 / pharmacology*
  • Interleukin-4 / pharmacology*
  • Lymphocyte Activation / drug effects
  • Lymphocytes, Tumor-Infiltrating / immunology*
  • Ovarian Neoplasms / immunology*
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocytes, Cytotoxic / immunology
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • CD8 Antigens
  • Interleukin-2
  • Tumor Necrosis Factor-alpha
  • Interleukin-4